Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Mind Gym revenue recovers; Dispersion buys Accru

Mon, 18th Oct 2021 15:12

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Mind Gym PLC - London-based training and management development company - Expects revenue of GBP24.1 million in the six months ended September 30, up 66% year-on-year from GBP14.5 million. Revenue remained slightly above the GBP23.9 million reported in the comparative pre-Covid period, two years earlier. Says 82% of income was "digitally enabled". Continues to invest in its technological capacities ahead of the planned launches of its new digital products. Expects to release its interim results on December 3.

----------

Dispersion Holdings PLC - decentralised finance investor using blockchain and cryptocurrencies to remove financial intermediaries from transactions - Acquires Accru Finance Ltd for GBP8.8 million, to be paid via the issue of 250 million new company shares. Accru's sellers will then hold a 29% stake in Dispersion. The company says Accru plans to launch: "the first internationally-regulated and insured platform for the trading and yield farming of cryptocurrencies." Expects to approve the deal at the company's general meeting next Tuesday.

----------

IXICO PLC- AI data analytics company based in London - Reports revenue of GBP9.2 million in the year ended September 30, down 3.2% from GBP9.5 million a year prior but 5.7% above market expectations of GBP8.7 million. Expects earnings before interest, tax, depreciation and amortisation of GBP1.2 million, in line with market expectations but slightly below the GBP1.3 million taken a year earlier. Notes that this reflects the GBP7.1 million adverse impact of lost revenue from the end of its Huntington's Disease trial in March. Expects lower profitability in financial 2022 as the company invests in long-term sustained growth.

----------

7digital Group PLC - London-based music licensing provider - Secures GBP1 million expansion to revolving credit facility with Investec Bank. Brings total facility with Investec up to GBP2 million total. Says the enlarged facility matures in September 2023, in keeping with the original terms agreed with the bank in September 2020. Issues 5.4 million warrants with an excise price of 0.55 pence and a lifespan of 36 months, as an arrangement fee to Investec.

----------

Artisanal Spirits Co PLC - Edinburgh, Scotland-based owner of the Scotch Malt Whisky Society - Signs 10-year lease for a new supply chain facility in Uddingston, Scotland. Says the 37,000 square foot facility will provide the company with greater control over its supply chain, in order to improve its margins over time. It includes warehousing, production and office space, with equipment due to be installed in early 2022. The facility is scheduled to become fully operation in the second half of 2022, the company adds.

----------

Destiny Pharma PLC - Brighton, England-based clinical stage biotechnology company focused on life threatening infections - Says US hospital-based study supports potential of XF-73 nasal product to reduce intensive care unit infections. The phase 4 study includes 300,000 patients and shows 23% of all ICU infections are caused by the staphylococcus aureus bacteria. Proposes its XF-73 product as an alternative to mupirocin for these infections. Notes current regulatory talks concerning phase 3 studies to obtain marketing approval for XF-73 in the US and Europe.

----------

ReNeuron Group PLC - Bridgend, Wales-based exosome therapeutics company - Sees first subject treated at Oxford Eye Hospital in a Phase 2a RP trial of its therapeutic candidate for retinitis pigmentosa, a degenerative eye disease. The study uses 2 million cell doses on subjects with some remaining vision, despite having advanced retinitis pigmentosa. Appoints Catherine Isted as chief financial officer and executive director. Notes the departure of non-executive director Chris Evans as he approaches non-independent status after nine years on the board.

----------

Hemogenyx Pharmaceuticals PLC - London-based developer of drugs for blood diseases - Leases custom laboratory at the Mink Building in New York from The Janus Property Co. Says the new laboratory is close to Columbia University and City College, possibly easing future collaboration. The 10,000 square foot laboratory includes two purpose built clean rooms. The company says the new space will be used to pursue commercialisation of its major cell therapy product candidates by manufacturing cells in-house, starting with its HEMO-CAR-T treatment for acute myeloid leukemia.

----------

Corcel PLC - London-based mineral explorer and developer with interests in battery metals and flexible energy generation & storage - Acquires Wo Wo Gap Nickel-Cobalt project in Papua New Guinea. Says it acquired the project as it reached a share purchase agreement with Resource Mining Corp Ltd to acquire the entire issued share capital of the project's owner Niugini Nickel Pty Ltd. "Near term priorities at Wo Wo gap will include resource updates, exploring synergies with our Mambare project, and the early securing of long term shipping and offtake arrangements," says Corcel's executive chair James Parsons.

----------

IGas Energy PLC - Lincoln-based oil and gas producer - Agrees head of terms with Iona Capital Ltd to develop utility scale solar farms in the UK. Initially plans to develop a 25 to 40 megawatt solar farm in southern England, the first of several similar projects. "IGas will contribute its planning and infrastructure expertise, whilst Iona will provide non-recourse project finance. During the development phase, costs will be shared and throughout the project lifecycle, IGas and Iona will each own 50% of the project," the company says.

----------

Gem Diamonds Ltd - London-based miner - Recovers high quality Type 2, 245 carat Type 2 and 102 carat white diamonds. Says it uncovered the stones from the Letseng mine in Lesotho, "the highest dollar per carat kimberlite diamond mine in the world".

----------

Ethernity Networks Ltd - Networking and security solutions provider based in Israel - Secures USD3 million order with Chinese broadband network OEM. Says the order is for customised FPGA system-on-chip processors and covers 2022 and 2023. Expecs further orders thereafter. Under the terms of the agreement, the company will supply OEM with its system-on-chip devices with support for four Gigabit Passive Optical Networking Optical Line Termination ports and four 10Gbps XGS-PON OLT MAC ports by the second quarter of 2022. These products support OEM's 5G and fibre access developments.

----------

Castillo Copper Ltd - Australia and Zambia-focused base metal copper exploration company - Begins drilling at its Arya Copper Prospect in the Mount Isa region of Queensland, Australia. Says drilling follows a significant logistical effort to prepare the drill-pads, heli-lift and other equipment at the site. Plans to drill five initial holes as "proof of concept" at the Arya site and expects to expand the campaign to fully test the area. Focuses drilling on targets identified by BHP in the 1990s, including EG01, EG02 and EG101,2. Notes large a potential 130 metre-thick sulphide bedrock conductor at the EG01 target. Says initial observations are encouraging. Notes concurrent rock chip sampling campaign to extend the known surface anomaly to the south.

----------

React Group PLC - South Derbyshire, England-based cleaning, hygiene and decontamination firm - Wins GBP230,000 contract to provide specialist deep cleaning services for a rail sector client. The contract runs for 25-weeks through to the end of March 2022, the company adds. "Securing this contract highlights the quality and depth of work being provided by the specialist teams within the group and continues to strengthen our presence in the rail sector," says Chief Executive Shaun Doak.

----------

Home REIT PLC - London-based real estate investment trust - Spends GBP166.4 million on property pipeline. Acquires 23 portfolios including 366 properties across England and Wales. Funds the purchases with proceeds from its oversubscribed GBP350 million equity issue in September. Says its total property pipeline totals GBP400 million.

----------

By Scarlett Butler; scarlettbutler@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
17 Apr 2024 11:58

ReNeuron CFO steps down to pursue other opportunities

(Alliance News) - ReNeuron Group PLC on Wednesday announced Chief Financial Officer John Hawkins will be stepping down from his role on May 7.

Read more
20 Mar 2024 18:11

TRADING UPDATES: ReNeuron appoints administrators as rescue talks fail

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Feb 2024 20:23

TRADING UPDATES: ReNeuron warns; Gama Aviation pledges cash return

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
8 Nov 2023 12:21

ReNeuron interim loss narrows on lower costs; eyes partnerships

(Alliance News) - ReNeuron Group PLC on Wednesday reported a slight narrowing in interim loss as costs decreased, as it highlighted its focus on its exosome delivery platform.

Read more
4 Sep 2023 11:10

ReNeuron reaches exosome research milestone

(Sharecast News) - UK-based biotechnology company ReNeuron Group, which specialises in stem cell-derived exosome technologies, announced significant advancements in the field of exosome research on Monday.

Read more
4 Sep 2023 10:24

IN BRIEF: ReNeuron makes progress on exosome delivery platform

ReNeuron Group PLC - Brigend, Wales-based stem cell and exosomes technology company - Generates in vivo data to exemplify cellular and tissue targeting capabilities of exosomes, produced from its multiple conditionally immortalised producer cell lines. Exosomes are extracellular vesicles which carry nucleic acids, proteins, lipids and metabolites. Typically, they play important roles in immune response, tumour progression, and neurodegenerative diseases.

Read more
15 Aug 2023 15:45

UK shareholder meetings calendar - next 7 days

Wednesday 16 August 
Cadence Minerals PLCAGM
Calnex Solutions PLCAGM
NextEnergy Solar Fund LtdAGM
NFT Investments PLCAGM
StreaksAI PLCAGM
VSA Capital Group PLCAGM
Thursday 17 August 
Harvest Minerals LtdAGM
Quantum Exponential Group PLCAGM
Windward LtdAGM
Yourgene Health PLCGM and court meeting re takeover by Novacyt
Friday 18 August 
Adams PLCAGM
ME Group International PLCGM re proposed share buyback
Oxford BioDynamics PLCGM re placing
Pathfinder Minerals PLCGM re disposal of the subsidiary
Monday 21 August 
Calculus VCT PLCAGM
Home REIT PLCGM re changes to the investment policy
Tuesday 22 August 
Cake Box Holdings PLCAGM
ReNeuron Group PLCAGM
RUA Life Sciences PLCAGM
Smoove PLCAGM
STM Group PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
18 May 2023 15:03

UK earnings, trading statements calendar - next 7 days

Friday 19 May 
IQE PLCFull Year Results
Knights Group Holdings PLCTrading Statement
Smiths Group PLCQ3 Results
Titon Holdings PLCHalf Year Results
Tharisa PLCHalf Year Results
Monday 22 May 
Big Yellow Group PLCFull Year Results
Chrysalis Investments LtdTrading Statement
Henderson European Focus Trust PLCHalf Year Results
Kainos Group PLCFull Year Results
Pershing Square Holdings LtdQ1 Results
Ryanair Holdings PLCFull Year Results
Schroder Oriental Income Fund LtdHalf Year Results
Wincanton PLCFull Year Results
Tuesday 23 May 
Assura PLCFull Year Results
Avon Protection PLCHalf Year Results
Benchmark Holdings PLCHalf Year Results
Bytes Technology Group PLCFull Year Results
Caledonian Trust PLCFull Year Results
Calnex Solutions PLCFull Year Results
Cranswick PLCFull Year Results
Engage XR Holdings PLCFull Year Results
FD Technologies PLCFull Year Results
Forterra PLCFull Year Results
Harworth Group PLCTrading Statement
Helical PLCFull Year Results
Hilton Food Group PLCTrading Statement
Ixico PLCHalf Year Results
JPMorgan China Growth & Income PLCHalf Year Results
Pebble Group PLCFull Year Results
Princess Private Equity Holding LtdQ1 Results
Residential Secure Income PLCHalf Year Results
RS Group PLCFull Year Results
Schroder AsiaPacific Fund PLCHalf Year Results
Seraphim Space Investment Trust PLCQ1 Results
SSP Group PLCHalf Year Results
Topps Tiles PLCHalf Year Results
Trellus Health PLCFull Year Results
Victorian Plumbing Group PLCHalf Year Results
Watkin Jones PLCHalf Year Results
Wednesday 24 May 
Aviva PLCTrading Statement
Bakkavor Group PLCTrading Statement
Bodycote PLCTrading Statement
C&C Group PLCFull Year Results
Close Brothers Group PLCTrading Statement
Ediston Property Investment Co PLCHalf Year Results
Empiric Student Property PLCTrading Statement
Esken LtdFull Year Results
Great Portland Estates PLCFull Year Results
Gym Group PLCTrading Statement
HICL Infrastructure PLCFull Year Results
Intertek Group PLCTrading Statement
Kier Group PLCTrading Statement
Kingfisher PLCQ1 Results
LondonMetric Property PLCFull Year Results
Majedie Investments PLCHalf Year Results
Marks & Spencer Group PLCFull Year Results
Mediclinic International PLCFull Year Results
Mortgage Advice Bureau Holdings PLCTrading Statement
N Brown Group PLCFull Year Results
Petershill Partners PLCTrading Statement
Purplebricks Group PLCTrading Statement
Regional REIT LtdTrading Statement
Severn Trent PLCFull Year Results
Sondrel Holdings PLCFull Year Results
SSE PLCFull Year Results
Tullow Oil PLCTrading Statement
Wynnstay Properties PLCFull Year Results
Zotefoams PLCTrading Statement
Thursday 25 May 
AJ Bell PLCHalf Year Results
Blackrock Frontiers Investment Trust PLCHalf Year Results
Caledonia Investments PLCFull Year Results
CT Private Equity Trust PLCQ1 Results
DWF Group PLCTrading Statement
Edinburgh Investment Trust PLCFull Year Results
Fevertree Drinks PLCTrading Statement
Headlam Group PLCTrading Statement
Henry Boot PLCTrading Statement
Hill & Smith PLCTrading Statement
Inspecs Group PLCTrading Statement
Intermediate Capital Group PLCFull Year Results
Jadestone Energy PLCFull Year Results
Johnson Mattey PLCFull Year Results
Pets At Home Group PLCFull Year Results
Pharos Energy PLCTrading Statement
Picton Property Income LtdFull Year Results
Qinetiq Group PLCFull Year Results
ReNeuron Group PLCFull Year Results
Renewi PLCFull Year Results
S&U PLCTrading Statement
Sabre Insurance Group PLCQ1 Results
Shires Income PLCFull Year Results
Tate & Lyle PLCFull Year Results
Triad Group PLCFull Year Results
United Utilities Group PLCFull Year Results
Vanquis Banking Group PLCTrading Statement
Workspace Group PLCFull Year Results
Young & Co's Brewery PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
24 Jan 2023 14:44

Director dealings: Reneuron CFO makes share purchase

(Sharecast News) - Reneuron revealed on Tuesday that chief financial officer John Hawkins had acquired 100,000 ordinary shares in the AIM-listed stem cell technologies group.

Read more
19 Jan 2023 14:29

IN BRIEF: ReNeuron reduces headcount by 40%; to focus on CustomEX data

ReNeuron Group PLC - Bridgend, Wales-based stem cell and exosomes technology company - Says it has reduced its headcount by 40% following company restructuring. The company says variable costs of the business have been lowered, with the resulting cash runway now extending to 2024. ReNeuron says its focus is generating in vivo data to validate its exosome delivery technology platform, CustomEx. CustomEx is a drug delivery platform which can be optimised for specific tissue targets leading to improvements in outcome for the patient.

Read more
3 Jan 2023 11:21

ReNeuron Chair Iain Ross moves to executive chair as CEO departs

(Alliance News) - ReNeuron Group PLC on Tuesday said its chief executive officer has left immediately, replaced by an executive chair.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
2 Dec 2022 12:47

ReNeuron shares tumble after first-half results

(Sharecast News) - Stem-cell-derived exosome technology specialist ReNeuron Group reported first-half revenue of £0.44m on Friday, up from £0.06m year-on-year, related to income from partner-funded development activities and royalty income.

Read more
2 Dec 2022 10:40

AIM WINNERS & LOSERS: Orosur Mining drops on disappointing assays

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
2 Dec 2022 09:31

ReNeuron loss narrows amid lower costs and surging revenue

(Alliance News) - ReNeuron Group PLC on Friday said its loss narrowed in the first half of its financial year, following lower costs, increased revenue and foreign exchange gains.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.